[Rational control on postoperative blood glucose levels in infants with congenital heart disease]

Mei Liu1, Ping Zheng, Xiao-ying Zheng

  • 1Intensive Care Unit, Shenzhen Second People's Hospital, Shenzhen 518000, Guangdong, China. mei_l82@qq.com

Insights

Intensive blood glucose control in infants undergoing heart surgery may increase hypoglycemia risk. Active control balances benefits and risks, reducing infection markers without significant hypoglycemia.

Area of Science:

  • Pediatric Cardiology
  • Critical Care Medicine
  • Metabolic Disorders

Context:

  • Congenital heart disease (CHD) necessitates open-heart surgery in infants.
  • Post-operative hyperglycemia is a concern in these vulnerable patients.
  • Optimal blood glucose management strategies require investigation.

Purpose:

  • To determine the ideal post-operative blood glucose control level for infants with congenital heart disease (CHD).
  • To compare the effects of intensive, active, and common glucose control strategies on post-operative outcomes.

Summary:

  • 102 infants undergoing open-heart surgery were randomized into intensive (A), active (B), and common (C) glucose control groups.
  • Group A targeted glucose levels ≤8.3 mmol/L, Group B ≤15.0 mmol/L, and Group C ≤18.0 mmol/L.
  • Outcomes including white blood cell count (WBC), C-reactive protein (CRP), pulmonary infection, hypoglycemia, and liver function were assessed.

Impact:

  • Severe hyperglycemia correlated with increased WBC, CRP, and pulmonary infection rates.
  • Intensive control (Group A) led to higher hypoglycemia incidence.
  • Active control (Group B) showed promise by reducing ALT levels and infection markers without significant hypoglycemia risk.
Abstract

Related Concept Videos

Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...